CYP17,20 lyase

metastatic hormone sensitive prostate cancer (21 products)

metastatic castration-sensitive prostate cancer (15 products)

Prostate cancer (12 products)

Advanced or metastatic prostate cancer (8 products)

recurrent prostate cancer (7 products)

de novo metastatic castration-sensitive prostate cancer (5 products)

non-metastatic castration-resistant prostate cancer (4 products)

Metastatic Cancer (3 products)

metastatic hormone-naive prostate cancer (2 products)

hormone-naive prostate cancer with pelvic lymph node metastases (2 products)

high-volume metastatic hormone-sensitive prostate cancer (2 products)

PSA-recurrent, non-metastatic, non-castrate prostate cancer (2 products)

De novo metastatic castration-sensitive prostate cancer (mCSPC) (2 products)

Advanced and metastatic prostate cancer (1 products)

Localized Prostate Cancer (1 products)

Prostate cancer with COVID-19 (1 products)

HR+/HER2- metastatic breast cancer (1 products)

HER2-negative, hormone-receptor positive metastatic breast cancer (1 products)

Low-risk prostate cancer (1 products)

metastatic hormone-resistant prostate cancer (1 products)